Related Experiment Video
Updated: Mar 16, 2026
Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
GDF11 administration does not extend lifespan in a mouse model of premature aging
Sandra Freitas-Rodríguez1, Francisco Rodríguez1, Alicia R Folgueras1
1Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.
Abstract:
GDF11 has recently emerged as a powerful anti-aging candidate, found in young blood, capable of rejuvenating a number of aged tissues, such as heart, skeletal muscle and brain. However, recent reports have shown contradictory data questioning its capacity to reverse age-related tissue dysfunction. The availability of a mouse model of accelerated aging, which shares most of the features occurring in physiological aging, gives us an excellent opportunity to test in vivo therapies aimed at extending lifespan both in pathological and normal aging. On this basis, we wondered whether the proposed anti-aging functions of GDF11 would have an overall effect on longevity. We first confirmed the existence of a reduction in GDF11/8 levels in our mouse model of accelerated aging compared with wild-type littermates. However, we show herein that GDF11 daily administration does not extend lifespan of premature-aged mice.
Insights
Growth Differentiation Factor 11 (GDF11) shows potential anti-aging effects. However, daily GDF11 administration did not extend lifespan in a mouse model of accelerated aging, despite reduced GDF11/8 levels.
Area of Science:
- Gerontology and regenerative medicine
- Molecular biology and aging research
Background:
- Growth Differentiation Factor 11 (GDF11) is a protein found in young blood, with proposed rejuvenating effects on aged tissues.
- Contradictory findings exist regarding GDF11's efficacy in reversing age-related dysfunction.
- Accelerated aging mouse models offer a platform to test longevity interventions.
Purpose of the Study:
- To investigate the overall effect of GDF11 on longevity in a mouse model of accelerated aging.
- To determine if GDF11 administration can extend lifespan in premature aging.
Main Methods:
- Confirmation of reduced GDF11/8 levels in accelerated aging mice compared to wild-type littermates.
- Daily administration of GDF11 to premature-aged mice.
- Assessment of lifespan extension in treated mice.
Main Results:
- Reduced GDF11/8 levels were confirmed in the accelerated aging mouse model.
- Daily GDF11 administration did not result in an extended lifespan for premature-aged mice.
Conclusions:
- GDF11 administration does not appear to extend lifespan in this model of accelerated aging.
- Further research is needed to fully elucidate GDF11's role in aging and longevity.
